Treatment-refractory depression: A case of successful treatment with intranasal ketamine 10%

Annals of Clinical Psychiatry

Volumn 26, Issue 1, 2014, Pages e10-

  Clark, Patricia ^a  

^a Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; KETAMINE; LEUCYLMETHYLFOLATE; MIRTAZAPINE; OLANZAPINE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; CASE REPORT; DISEASE EXACERBATION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; LETTER; MAJOR DEPRESSION; MIGRAINE; MONOTHERAPY; SUICIDAL IDEATION; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE;

EID: 84906995231     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Brauser D. Experimental drug may help depression 'in minutes." Medscape. http://www.medscape.com/viewarticle/776127. Published December 13, 2012. Accessed January 13, 2014.
2. Stetka B, Feifel D. Hope in treatment-refractory depression. Medscape. http://www.medscape.com/viewarticle/777190. Published January 10, 1013. Accessed January 13, 2014.
3. Pierson R. New J&J anti-depressant related to 'Special K' party drug. Reuters. http://www.reuters. com/article/2013/05/23/us-johnsonjohnson-investors-idUSBRE94M0J120130523. Published May 23, 2013. Accessed January 13, 2014.
4. National Institute of Mental Health. Ketamine cousin rapidly lifts depression without side effects. http://www. nimh.nih.gov/news/science-news/2013/ketamine-cousin-rapidly-lifts-depression-without-side-effects. shtml. Published May 23, 2013. Accessed January 13, 2014.